Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
Saved in:
| Title: | Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. |
|---|---|
| Authors: | Unger JM; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Qian L; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Tavernier SS; Idaho State University, Pocatello, ID, USA., Minasian L; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA., Sigal EV; Friends of Cancer Research, Washington, DC, USA., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA., Leblanc M; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Cleeland CS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dzingle SA; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA., Summers TJ; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA., Chao H; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA., Madhusudhana S; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA., Villaruz L; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA., Crawford J; Duke Cancer Institute, Durham, NC, USA., Gray JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kelly KL; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Herbst RS; Yale Cancer Center, New Haven, CT, USA., Gettinger SN; Yale Cancer Center, New Haven, CT, USA., Moinpour CM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446. |
| Publication Type: | Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36625510 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Unger+JM%22">Unger JM</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Qian+L%22">Qian L</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Redman+MW%22">Redman MW</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Tavernier+SS%22">Tavernier SS</searchLink>; Idaho State University, Pocatello, ID, USA.<br /><searchLink fieldCode="AU" term="%22Minasian+L%22">Minasian L</searchLink>; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sigal+EV%22">Sigal EV</searchLink>; Friends of Cancer Research, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Papadimitrakopoulou+VA%22">Papadimitrakopoulou VA</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Leblanc+M%22">Leblanc M</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Cleeland+CS%22">Cleeland CS</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dzingle+SA%22">Dzingle SA</searchLink>; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Summers+TJ%22">Summers TJ</searchLink>; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Chao+H%22">Chao H</searchLink>; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Madhusudhana+S%22">Madhusudhana S</searchLink>; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Villaruz+L%22">Villaruz L</searchLink>; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Crawford+J%22">Crawford J</searchLink>; Duke Cancer Institute, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Gray+JE%22">Gray JE</searchLink>; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+KL%22">Kelly KL</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gandara+DR%22">Gandara DR</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bazhenova+L%22">Bazhenova L</searchLink>; University of California San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Herbst+RS%22">Herbst RS</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Yale Cancer Center, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Moinpour+CM%22">Moinpour CM</searchLink>; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36625510 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jnci/djad003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 437 Titles: – TitleFull: Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Unger JM – PersonEntity: Name: NameFull: Qian L – PersonEntity: Name: NameFull: Redman MW – PersonEntity: Name: NameFull: Tavernier SS – PersonEntity: Name: NameFull: Minasian L – PersonEntity: Name: NameFull: Sigal EV – PersonEntity: Name: NameFull: Papadimitrakopoulou VA – PersonEntity: Name: NameFull: Leblanc M – PersonEntity: Name: NameFull: Cleeland CS – PersonEntity: Name: NameFull: Dzingle SA – PersonEntity: Name: NameFull: Summers TJ – PersonEntity: Name: NameFull: Chao H – PersonEntity: Name: NameFull: Madhusudhana S – PersonEntity: Name: NameFull: Villaruz L – PersonEntity: Name: NameFull: Crawford J – PersonEntity: Name: NameFull: Gray JE – PersonEntity: Name: NameFull: Kelly KL – PersonEntity: Name: NameFull: Gandara DR – PersonEntity: Name: NameFull: Bazhenova L – PersonEntity: Name: NameFull: Herbst RS – PersonEntity: Name: NameFull: Gettinger SN – PersonEntity: Name: NameFull: Moinpour CM IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2023 Apr 11 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1460-2105 Numbering: – Type: volume Value: 115 – Type: issue Value: 4 Titles: – TitleFull: Journal of the National Cancer Institute Type: main |
| ResultId | 1 |